| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenue | 33,255 | 35,411 | 32,904 | 27,937 |
| Cost of sales | 11,263 | 11,127 | 12,661 | 11,630 |
| Gross profit | 21,992 | 24,284 | 20,243 | 16,307 |
| General and administrative | 7,071 | 7,478 | 7,533 | 7,493 |
| Sales and marketing | 11,746 | 11,616 | 11,204 | 11,890 |
| Research and development | 634 | 566 | 443 | 701 |
| Total operating expenses | 19,451 | 19,660 | 19,180 | 20,084 |
| Income (loss) from operations | 2,541 | 4,624 | 1,063 | -3,777 |
| Interest expense | 904 | 1,004 | 1,045 | 1,199 |
| Unrealized foreign currency translation (loss) gain | -56 | 178 | 24 | 27 |
| Other expense | -16 | 7 | -9 | -13 |
| Total other expense | -976 | -819 | -1,030 | -1,185 |
| Net income (loss) from operations before provision for income taxes | 1,565 | 3,805 | 33 | -4,962 |
| Provision for income taxes current and deferred | 257 | 255 | -25 | 62 |
| Net income (loss) | 1,308 | 3,550 | 58 | -5,024 |
| Basic | 0.01 | 0.03 | 0 | -0.04 |
| Basic | 139,712,969 | 139,310,589 | 139,068,831 | 135,100,233 |
| Dilutive | 0.01 | 0.02 | 0 | -0.04 |
| Dilutive | 150,377,234 | 148,574,242 | 143,335,114 | 135,100,233 |
Xtant Medical Holdings, Inc. (XTNT)
Xtant Medical Holdings, Inc. (XTNT)